ADVFN Logo

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

GSK Gsk Plc

1,708.60
3.40 (0.20%)
2024年3月29日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Gsk Plc GSK ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
3.40 0.20% 1,708.60 01:29:59
始値 安値 高値 終値 前日終値
1,701.60 1,699.40 1,713.00 1,708.60 1,705.20
この銘柄の詳細情報 »
業種
PHARMACEUTICALS & BIOTECHNOLOGY

最新ニュース

日付 時間 ソース タイトル
2024/3/2700:30UK RNSGSK PLC Director/PDMR Shareholding
2024/3/2522:00UK RNSGSK PLC Notice of AGM
2024/3/2301:20UK RNSGSK PLC Transfer of Treasury Shares
2024/3/2300:36UK RNSGSK PLC Director/PDMR Shareholding
2024/3/1818:30UK RNSGSK PLC New Phase III Jemperli data in endometrial cancer
2024/3/1817:47ALNCNewsGSK says Jemperli combination gets good results for..
2024/3/1400:48UK RNSGSK PLC Director/PDMR Shareholding
2024/3/0902:12UK RNSGSK PLC Board Committee Change
2024/3/0718:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
2024/3/0716:00UK RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
2024/3/0701:00UK RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
2024/3/0602:24UK RNSGSK PLC GSK Annual Report 2023 on Form 20-F
2024/3/0520:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
2024/3/0516:00UK RNSGSK PLC New ViiV LA formulation potential 4-month dosing
2024/3/0200:00UK RNSGSK PLC Total Voting Rights
2024/3/0121:15UK RNSGSK PLC GSK publishes Annual Report 2023
2024/2/2918:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
2024/2/2916:05UK RNSGSK PLC Directorate Change
2024/2/2916:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
2024/2/2700:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/2617:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
2024/2/2616:00UK RNSGSK PLC GSK announces positive EAGLE-1 headline results
2024/2/2300:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/2118:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
2024/2/2116:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
2024/2/2018:01UK RNSGSK PLC Julie Brown - External Appointment
2024/2/2000:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1600:32UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1517:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
2024/2/1516:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
2024/2/1401:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
2024/2/1400:40UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1400:35UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1400:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1317:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
2024/2/1300:39UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1300:38UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1300:26UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1220:36ALNCNewsIN THE KNOW: Goldman Sachs highlights value in magnificent..
2024/2/1217:35ALNCNewsTOP NEWS: GSK's bepirovirsen receives US FDA fast track..
2024/2/1216:00UK RNSGSK PLC US FDA Fast Track designation for bepirovirsen
2024/2/0821:00UKREGAlector Announces First Patient Dosed in PROGRESS-AD Phase 2..
2024/2/0806:01UKREG23andMe Reports Third Quarter Fiscal 2024 Financial Results
2024/2/0617:51ALNCNewsTOP NEWS: GSK reports positive news on trio of high profile..
2024/2/0616:10UK RNSGSK PLC FDA accepts Arexvy filing for adults 50-59 at risk
2024/2/0616:05UK RNSGSK PLC Shingrix 18+ at risk China filing review accepted
2024/2/0616:00UK RNSGSK PLC GSK presents positive DREAMM-7 phase III data
2024/2/0200:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/0200:00UK RNSGSK PLC Total Voting Rights
2024/2/0118:27ALNCNewsTOP NEWS: GSK maintains "vigorous" defence after settling..

最近閲覧した銘柄

Delayed Upgrade Clock